Quantitative DNA perturbations of p53 in endometriosis: analysis of American and Icelandic cases.
Cast your vote
You can rate an item by clicking the amount of stars they wish to award to this item.
When enough users have cast their vote on this item, the average rating will also be shown.
Your vote was cast
Thank you for your feedback
Thank you for your feedback
AuthorsGylfason, Jon Torfi
Benediktsdottir, Kristrun R
Geirsson, Reynir T
Buster, John E
Carson, Sandra A
Simpson, Joe Leigh
Bischoff, Farideh Z
MetadataShow full item record
CitationFertil. Steril. 2005, 84(5):1388-94
AbstractOBJECTIVE: To investigate quantitative aberrations involving p53 copy numbers in eutopic endometrial and endometriotic tissue from two populations. DESIGN: Comparative analysis of normal and diseased tissue. SETTING: Tissue specimens collected in Iceland and USA. PATIENT(S): Subjects with moderate/severe endometriosis (Iceland, n = 26; USA, n = 45). Paraffin-embedded tissue from 19 matched Icelandic cases and seven unaffected controls. American cases were fresh surgical tissue from 17 matched cases and 28 unaffected controls. DNA isolation and real-time polymerase chain reaction (PCR) with TaqMan assay were performed. MAIN OUTCOME MEASURE(S): The frequency of p53 loss and/or gain based on quantitative differences for copy numbers of p53 located on chromosome (17p) and GAPDH on a control locus (chromosome 12p). RESULT(S): Among American cases, significant p53 gain (n = 13) or loss (n = 4) was observed in 17 of 21 cases. In Icelandic cases this was not seen to the same degree. Mean normalized p53 values were 3.46 and 1.16 copies per reaction, respectively. Significant differences were observed between normalized p53 in the control blood and affected tissue for the American and Icelandic cases compared to standard GAPDH control but not in normal Icelandic and American endometrium. CONCLUSION(S): The results continue to support a role for nonrandom somatic p53 locus alterations in the pathogenesis of late or severe-stage endometriosis. Differences between Icelandic and American subjects have implications for generalization of genome-wide approaches.
DescriptionTo access publisher full text version of this article. Please click on the hyperlink in Additional Links field
- Somatic DNA alterations in endometriosis: high frequency of chromosome 17 and p53 loss in late-stage endometriosis.
- Authors: Bischoff FZ, Heard M, Simpson JL
- Issue date: 2002 May-Jun
- Microsatellite DNA assays reveal an allelic imbalance in p16(Ink4), GALT, p53, and APOA2 loci in patients with endometriosis.
- Authors: Goumenou AG, Arvanitis DA, Matalliotakis IM, Koumantakis EE, Spandidos DA
- Issue date: 2001 Jan
- Endometrial and peritoneal expression of aromatase, cytokines, and adhesion factors in women with endometriosis.
- Authors: Kyama CM, Overbergh L, Mihalyi A, Meuleman C, Mwenda JM, Mathieu C, D'Hooghe TM
- Issue date: 2008 Feb
- Analysis of aromatase and 17beta-hydroxysteroid dehydrogenase type 2 messenger ribonucleic acid expression in deep endometriosis and eutopic endometrium using laser capture microdissection.
- Authors: Matsuzaki S, Canis M, Pouly JL, Déchelotte PJ, Mage G
- Issue date: 2006 Feb
- Differential interleukin-6 messenger ribonucleic acid expression and its distribution pattern in eutopic and ectopic endometrium.
- Authors: Salmassi A, Acil Y, Schmutzler AG, Koch K, Jonat W, Mettler L
- Issue date: 2008 May